MDR Vivacit-E Elevated Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

52 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-10

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to confirm long-term safety, performance, and clinical benefits of the Vivacit-E Vitamin E HXLPE Elevated Liners when used in primary total hip arthroplasty.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Vivacit-E Post-market Follow-up Study

NCT03226808

Osteoarthritis Avascular Necrosis of Bone of Hip Post-traumatic; Arthrosis +1 more

ACTIVE_NOT_RECRUITING NA

A Prospective Study to Evaluate the Effectiveness of a Haemostatic Agent in Primary Unilateral Total Hip Arthroplasty

NCT01285024

Arthritis

COMPLETED NA

AESCULAP® Plasmafit® Cementless Acetabular System With Vitelene® Vitamin E Stabilized Highly Crosslinked Polyethylene

NCT05291130

Osteoarthritis, Hip Rheumatic Arthritis Degenerative Osteoarthritis

COMPLETED

Long-Term Multi-center Evaluation of E-Poly and Regenerex

NCT00545285

Osteoarthritis of Hip Traumatic Arthritis of Hip

UNKNOWN NA

Post Market Study of the 3DKnee™ With E-plus Insert

NCT01551472

Degenerative Joint Disease Osteoarthritis Traumatic Arthritis

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis (OA) of the Hip Avascular Necrosis of Bone of Hip Protrusio Acetabuli Traumatic Arthropathy-Hip Slipped Capital Femoral Epiphyses Fused Hip Fracture of Pelvis Diastrophic Variant

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vivacit-E Elevated Liners

Patients previously implanted with Vivacit-E Elevated Liners.

Vivacit-E Elevated Liners

Intervention Type DEVICE

Primary total hip arthroplasty

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vivacit-E Elevated Liners

Primary total hip arthroplasty

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient was 18 years of age or older and skeletally mature at the time of surgery
* Patient qualified for and underwent surgical procedure with a Vivacit-E Vitamin E HXLPE Elevated Liner to treat one of the following indications in primary THA:
* Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis
* Protrusio acetabuli
* Traumatic arthritis
* Slipped capital epiphysis
* Fused hip
* Fracture of the pelvis
* Diastrophic variant
* Patient underwent surgical procedure 10 years (+ no maximum/- 182 days) prior to date of study consent
* Patient is will and able to sign IRB approved Informed Consent Form or provide verbal consent

Exclusion Criteria

* Off label use or not according to the approved IFU at the time of surgery
* Patient presented with any of the following at the time of the surgical procedure:
* Osteoradionecrosis
* Neuromuscular compromise, vascular deficiency or other conditions in the affected limb that may lead to inadequate skeletal fixation
* Systemic or local infection
* Revision procedure where other treatment or devices have failed\*
* Patient has a psychiatric illness or cognitive deficit that will not allow for proper informed consent
* Uncooperative patient or patient with neurologic disorders who is incapable or unwilling to follow directions

* For the purpose of this clinical study; a revision procedure refers to a procedure in which the prior procedure on the ipsilateral hip utilized a similar approach (i.e., primary total hip arthoplasty)

Eligible Sex

ALL

Accepts Healthy Volunteers

No